Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting State

NCT07568652 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Diabete Type 2

Interventions

DRUG: Test group 1
DRUG: Test group 2

Sponsor

Hanlim Pharm. Co., Ltd.